The use of stents has improved results after balloon carotid angioplasty. Some materials have been reported for covering the metal surface of the stent to reduce the rate of subacute thrombosis and restenosis. We have already developed a new stent graft with thin-walled controlled micropored polymer covering, and in a previous study we confirmed tissue ingrowth via the micropores at one month in a beagle model. The progress of cell migration was controlled by micropore density using a constant micropore diameter (30J.1m diameter, 125J.1m inter-pore distance). In the present study, we applied our newly developed stent graft impregnated with heparin for implantation in the rabbit carotid artery, and carried out an angiographic and histological investigation. Our stent graft was made from a Palmaz-Schatz stent and a micropored segmental polyurethane (SPU) thin film with a heparin coating. Micropores 30J.1m in diameter and 125J.1m apart were created on the thin SPU film using an excimer laser ablation technique. The surface of the micropored film was then impregnated with photosensitive gelatin that incorporated the heparin. The metal stent was rolled up and fixed to this modified SPU film under microscopic observations. These stent grafts were deployed in the common carotid arteries (CCAs) of rabbits (37 carotid arteries, 20 rabbits). The animals were sacrificed one, two and three months later, and a histological study and scanning electron microscopy study were performed for evaluation of endoluminal endothelialization and intimal thickening at the late stage. CCAs treated with stent grafts of micropored film showed poor-patency and intimal hyperplasia compared with those treated with a simple bare stent or a heparin-impregnated stent. In terms of intimal hyperplasia and patency, the heparin-impregnated stent was superior to the bare stent. Intimal hyperplasia was prevented by control of tissue ingrowth through the micropores. The antithrombogenicity of the impregnated heparin improved patency in the early stage. Our new stent graft with a heparin-impregnated SPU film thus appears promising for prevention of restenosis due to neointimal hyperplasia.
Summary
The use of stents has improved results after balloon carotid angioplasty. Some materials have been reported for covering the metal surface of the stent to reduce the rate of subacute thrombosis and restenosis. We have already developed a new stent graft with thin-walled controlled micropored polymer covering, and in a previous study we confirmed tissue ingrowth via the micropores at one month in a beagle model. The progress of cell migration was controlled by micropore density using a constant micropore diameter (30J.1m diameter, 125J.1m inter-pore distance). In the present study, we applied our newly developed stent graft impregnated with heparin for implantation in the rabbit carotid artery, and carried out an angiographic and histological investigation. Our stent graft was made from a Palmaz-Schatz stent and a micropored segmental polyurethane (SPU) thin film with a heparin coating. Micropores 30J.1m in diameter and 125J.1m apart were created on the thin SPU film using an excimer laser ablation technique. The surface of the micropored film was then impregnated with photosensitive gelatin that incorporated the heparin. The metal stent was rolled up and fixed to this modified SPU film under microscopic observations. These stent grafts were deployed in the common carotid arteries (CCAs) of rabbits (37 carotid arteries, 20 rabbits). The animals were sacrificed one, two and three months later, and a histological study and scanning electron microscopy study were performed for evaluation of endoluminal endothelialization and intimal thickening at the late stage. CCAs treated with stent grafts of micropored film showed poor-patency and intimal hyperplasia compared with those treated with a simple bare stent or a heparin-impregnated stent. In terms of intimal hyperplasia and patency, the heparin-impregnated stent was superior to the bare stent. Intimal hyperplasia was prevented by control of tissue ingrowth through the micropores. The antithrombogenicity of the impregnated heparin improved patency in the early stage. Our new stent graft with a heparin-impregnated SPU film thus appears promising for prevention of restenosis due to neointimal hyperplasia.
Introduction
Some clinical trials reported that stents are more clinically than balloon carotid angioplasty (BCA). However, there are still problems with early or subacute thrombogenicity and severe late-stage intimal hyperplasia (restenosis) due to delayed endothelialization, the limited biocompatibility of metal stents, and vascular injury during the stenting procedure 1,2.3. We previously reported a newly developed stent graft incorporating a well-controlled micropored segmental polyurethane (SPU) film and its ability to provide long-term patency (1 month) after stenting in a beagle model 4 . In the present study, we applied those stent grafts to the common carotid arteries of rabbits and evaluated histological and angiographic ol}-tcomes (up to 3 months).
Material and methods

Experimental protocol 4
The endoluminal prostheses evaluated in this study were deployed in the common carotid arteries (CCAs, 37 carotids arteries) of Japanese white rabbits (20 rabbits, weight 2.5-3 kg). All the animals were cared for in compliance with the "Principles of Laboratory Animal Care" (formulated by the National Society for Med-ical Research) and the "Guide for the Care and Use of Laboratory Animals" (National Institutes of Health Publication, No. 86-23, revised 1985). Twenty bare stents, 10 stent grafts with micropored SPU films only, and 7 stent grafts with heparin-impregnated micropored SPU films were placed in alternate order in the left or right CA. All rabbits were adequately cared for, anesthetized during the stenting procedure, and finally euthanatized.
Fabrication of the stent graft with a simple micropored SPU thin film 4
For this study, our developed stent grafts were made from a Palmaz-Schatz balloon expandable metallic stent (1.5 mm in primary diameter, 15 mm in length, Cordis, Johnson & Johnson, Tokyo, Japan) and a microprocessed SPU thin film. Well-controlled micro pores (30/-1 m in diameter, 125/-1m apart) were created in a SPU thin film using the computer-assisted ex- Figure 2 Changes in neointimal thickness between 1 month and 3 months after implantation. Up to 2 months, two trends are evident. One is a relatively thick (400 flm) neointima in animals with non-treated micropored stents, and the other is a thin (200 flm) neointima in animals with bare stents and heparin-impregnated micropored stents. Thus, at this stage, in terms of neointimal thickness, heparinized stent grafts provide results somewhat superior to those for bare stents. At 3 months, however, there is no difference among the three groups. cimer laser (KrF) ablation technique 5. This micropored SPU film was then impregnated with photoreactive hydrogel combined with heparin. After coating with a 5 wt% aqueous solution of photo reactive gelatin including 2.5 % heparin and subsequent air-drying, the film was irradiated for 10 min with UV light from a mercury arc lamp (H-400P; Toshiba, Tokyo, Japan; A>270m/-l; intensity, 0.14 mW/cm2), and then non-reacted gelatin was removed by thorough washing. This procedure was repeated three times 3. The micropored SPU film and heparinimpregnated, micropored SPU film were sutured with 10.0 nylon thread, rolled up around the Palmaz-Schatz stents, and glued with dimethyl formamide under microscopic observation (figure 1). Each modified film was fixed at both ends of the stent strut to avoid dislocation, slippage or shortening. The coated stents were then sterilized with alcohol (05% (W/V) Maskin-ethanol) and irrigated with saline before use.
Stent graft implantation
Experiments were performed using rabbits (weight, about 3 kg). A PTA balloon (Savvy Balloon, Cord is, Johnson and Johnson, Tokyo, Japan) mounted and crimped down with a bare stent, or stent graft with or without heparin impregnation, was advanced to the CCA through the femoral artery (FA). As the FA is vulnerable to mechanical manipulation, and may become §p'asmodic, . papaverine hydrochloride was administered. The stents were deployed by inflation of the PTA balloon for 30 sec at 8 atm under fluoroscopic observation. The balloon was then repositioned to deploy the proximal and distal ends, respectively. A gross inspection and microscopic evaluation were performed at scheduled explantation.
Pathology
The animals were sacrificed at 1, 2, and 3 months for en block harvest of the stent specimens.
Most specimens were processed and embedded in acrylic to enable sectioning of the specimens without removing the struts from the tissue. Hematoxylin and eosin, and Masson's trichrome stains were used to identify the cellular elements and the presence of collagen. Scanning electron microscopy was performed on some specimens for evaluation of the surface architecture.
Results
The bare stent, micropored stent, or heparinimpregnated micropored stent mounted on a PTA mini balloon was smoothly inserted into the FA through a specially devised cartridge without any damage to the stent grafts, and advanced to the CCA. Eight bare stents, 4 covered stents, and 1 heparin-impregnated stent were implanted for 1 month. Three bare stents, 2 covered stents, and 2 heparin-impregnated stents were implanted for 2 months, and 9 bare stents,4 covered stents and 4 heparinized stents were implanted for 3 months.
Angiographic study
In the 20 animals with bare stents, all the stents were patent except 1 of the 3 removed after 2 months. In the 10 animals with covered stents, 4 of the stents were occluded, including 3 of the 4 removed after 1 month, and 1 of the 2 removed after 2 months. All of the heparin-impregnated stents remained patent, irrespective of implantation period.
Macroscopic findings
Deployment of all stents was more accurate and less complicated. All the patent stent grafts had well -incorporated luminal surfaces.
Microscopic findings
The heparin-impregnated stent grafts became fully incorporated, with a cellular, collagen-rich neointima. The stent struts became well incorporated with the neointima through the micropores, and the neointima completely encased the graft material. The stent struts did not appear to penetrate the internal elastic lamina. No inflammatory cells were seen near the stent struts, but occasional macrophages were observed near the graft material. Up to 2 months of implantation, the specimens were divisible into two groups according to the thickness of the neointima for the three types of implanted stents and stent grafts. One was a thinner group for bare stents (about 20011 m thick) and heparin-impregnated stent grafts, and the other was a thicker group for covered stents (about 400 I1m thick). At 3 months of implantation, there was no difference in neointimal thickness among the three types of implanted stents (figure 2).
SEM findings
In carotid arteries of the rabbits with bared stents and heparin-impregnated stent grafts, endothelial cell proliferation was evident 1 month after implantation. In those with bare stents, protrusion of the stent strut was seen, whereas those with heparin-impregnated stent grafts showed a smooth en do luminal surface.
Discussion
In this long-term normal rabbit model, we demonstrated the effectiveness of local drug delivery system using micropored heparin-impregnated SPU film incorporated with a stent graft for antithrombogenicity and control of tissue ingrowth from the surrounding luminal tissue via micro pores.
The rate of angiographic restenosis is reported lower in patients who undergo coronary stenting than in patients treated by conventional balloon angioplasty (22 % vs 32 %, respectively, in the BENESTENT triaJ6, and 32% vs 42%, respectively, in the STRESS trial 7). The incidence of restenosis, which is now known to be caused by both vessel remodeling and neointimal hyperplasia, might be reduced in the future by a combined mechanical and pharmacological approach.
Intimal hyperplasia (rH) and the elastic recoil mechanism (ERM) are believed to be the principal causes of restenosis following percutaneous arterial interventional procedures. Injury to the arterial wall (internal elastic lamina, media and, at times, adventitia) during transluminal angioplasty is the principal cause of IH, and the ERM continues to be a problem in atherosclerotic arteries. The use of endoluminal stents can prevent ERM following PTA and re-duce the degree of damage to smooth muscle, thus preventing the resulting fibrocellular proliferation from encroaching significantly on the arterial luminae while providing a scaffold for neoendothelialization. Our newly developed heparin-impregnated stent grafts are blood compatible while providing a low-profile expandable mechanical barrier for isolating vascular lesions. Thus, they would prevent angioplasty failure due to IH by supplying a healthy endothelial surface using a micropored SPU film and help to eliminate ERM in both stenosed and restenosed arteries because of their lower thrombogenicity 8. In the phase immediately following human coronary stenting, all endothelial cells are destroyed. Up to 16 days after stenting, complete destruction of the endothelial cell layer, resulting from implantation trauma, is evident. This severe endothelial alteration, as also seen after balloon injury 9 and atherectomy 10, initiates the formation of a thin multilayered membranous thrombus covering the vascular and stent surfaces. This thrombus functions as the endoluminallayer of the vessel wall in the first week after stenting, and is gradually infiltrated by smooth muscle cells (SMCs) secreting extracellular matrix material 11. In the early stage of endothelial denudation during stenting, heparin released from our heparin-impregnated stent grafts ensured that thrombus formation on the endoluminal surface and stent struts was only mild until sufficient reendothelialization had occurred. Early occlusion (at 1 month of implantation) was found in 4 of 10 arteries containing non-treated micropored stent grafts, whereas none of arteries containing heparinimpregnated stent grafts was occluded. In response to experimental arterial balloon denudation, there is a marked increase in expression of genes that encode collagen and elastin in the arterial wall 12 , and the medial SMC shows a shift in phenotype from a contractile to a synthetic form, proliferate, migrate through breaks in the internal elastic lamina and produce large amounts of extracellular matrix 13 . This growth response leads to the development of neointimal thickening also known as neointimal hyperplasia 1\ and this becomes maximal after 3 months by extracellular matrix of synthetic SMCs 11. A substantial reduction in neointimal volume might be obtained without the need to inhibit SMCs migration or prolifer-Interventional Neuroradiology 7 (Suppl1): [161] [162] [163] [164] [165] [166] 2001 ation. After 2 or 3 months, SMCs return to a contractile phenotype and no further significant increase in intimal thickening occurs in vivo 15 . Clinical restenosis may be avoided if ERM or IH can be prevented until 3 months of stenting by our newly developed heparin-impregnated stent. Considering that response may differ among various animal species, and that experimental stent implantation is done using undiseased artery segments, results obtained in animal studies might differ considerably from those using human arteriosclerotic arteries 11 . Accumulation of CD68-positive cells (macrophages) is due to intramural neointimal and media hematoma. Activated macrophages produce platelet-derived growth factor, which is one of the strongest known mitogenic factors for SMCs. Six months after stenting in humans, SMCs form the vessel surface 16.17. To ensure proper tissue ingrowth from surrounding luminal tissue via micropores, the optimal micropore size and distribution was previously determined to be 30llm diameter and 1251lm apart in beagles 4 . Mature endothelial cells act not only as a physiological barrier against in sudation into the vessel wall, but also as modulators of vascular tonus 18 and regulators of SMC proliferation. Lack of mature endothelium in the early incorporation phase and late re-endothelialization may act as cofactors in the process of exaggerated SMC proliferation 19. Proliferating endothelial cells do not contribute to neointimal generation, as documented in pathologicanatomic studies of human atherectomy mater-iaI 20 • Re-endothelialization has been observed 21 days after PTA of porcine carotid arteries. In dogs, complete endothelialization after experimental stenting was found 8 weeks after experimental stenting. A study using human coronary probes has shown that mature endothelium (factor VIII-positive cells of endothelial origin) completely covering the neointima was evident 3 months after stenting 11 . From SEM observations in our study demonstrated a confluent endothelial coverage on the endoluminal surface and the stent struts, even at 1 month after stenting in the rabbit CCA. Early re-endothelialization was attained by tissue ingrowth via the micropores on our heparin-impregnated stent graft. A fibrous cap on the atherosclerotic arterial surface and irregularities due to calcification hinder the uniform stent apposition to the arterial surface which is necessary for incorporation 21. Rupture of the necrotic core, with exposure of the plaque contents, appears to be a potent stimulus for inflammation and profuse proliferation of SMCs 22. Simple stent grafts providing a scaffold and allowing endothelial replacement would remove the factors responsible for stenosis. Furthermore, such stent grafts would supply a fresh, relatively undamaged, and not excessively distended intimal surface capable of secreting endothelium-derived relaxing factor and other neurohumoral substances responsible for vaso-regulation, thereby avoiding vaso constriction after PTA. The generally well-accepted events responsible for graft obstruction are thrombosis in the early phase of implantation and intimal hyperplasia in the latter phase.
